select a format

Single User License
USD 2500 INR 160400
Site License
USD 5000 INR 320800
Corporate User License
USD 7500 INR 481200

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2584CTIDB
  • |
  • Pages: 94
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015" provides data on the Extrahepatic Bile Duct Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Extrahepatic Bile Duct Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Extrahepatic Bile Duct Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Extrahepatic Bile Duct Cancer 5

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Countries Contributing to Clinical Trials in Asia-Pacific 9

Top Five Countries Contributing to Clinical Trials in Europe 10

Top Countries Contributing to Clinical Trials in North America 11

Clinical Trials by G7 Countries: Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials 12

Clinical Trials by Phase in G7 Countries 13

Clinical Trials in G7 Countries by Trial Status 14

Clinical Trials by Phase 15

In Progress Trials by Phase 16

Clinical Trials by Trial Status 17

Clinical Trials by End Point Status 18

Unaccomplished Trials of Extrahepatic Bile Duct Cancer 19

Subjects Recruited Over a Period of Time 21

Clinical Trials by Sponsor Type 22

Prominent Sponsors 23

Top Companies Participating in Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials 24

Prominent Drugs 25

Clinical Trial Profiles 26

Clinical Trial Overview of Top Companies 26

AstraZeneca PLC 26

Clinical Trial Overview of AstraZeneca PLC 26

PrECOG, LLC. 27

Clinical Trial Overview of PrECOG, LLC. 27

Daiichi Sankyo Company, Limited 28

Clinical Trial Overview of Daiichi Sankyo Company, Limited 28

Clinical Trial Overview of Top Institutes / Government 29

National Cancer Institute 29

Clinical Trial Overview of National Cancer Institute 29

Memorial Sloan Kettering Cancer Center 31

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 31

Massachusetts General Hospital 32

Clinical Trial Overview of Massachusetts General Hospital 32

National Institutes of Health Clinical Center 33

Clinical Trial Overview of National Institutes of Health Clinical Center 33

North Central Cancer Treatment Group 34

Clinical Trial Overview of North Central Cancer Treatment Group 34

University of Chicago 35

Clinical Trial Overview of University of Chicago 35

Mayo Clinic 36

Clinical Trial Overview of Mayo Clinic 36

SWOG 37

Clinical Trial Overview of SWOG 37

Northwestern University 38

Clinical Trial Overview of Northwestern University 38

Samsung Medical Center 39

Clinical Trial Overview of Samsung Medical Center 39

Five Key Clinical Profiles 40

Appendix 91

Abbreviations 91

Definitions 91

Research Methodology 92

Secondary Research 92

About GlobalData 93

Contact Us 93

Disclaimer 93

Source 94

List of Figures

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11

Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 12

Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 15

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 16

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Extrahepatic Bile Duct Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

GlobalData Methodology 92

List of Tables

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 6

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 11

Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 12

Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13

Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 15

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 16

Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18

Extrahepatic Bile Duct Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 19

Extrahepatic Bile Duct Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 20

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Extrahepatic Bile Duct Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 26

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PrECOG, LLC., 2015* 27

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 28

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 29

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 31

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 32

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2015* 33

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2015* 34

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015* 35

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 36

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015* 37

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 38

Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2015* 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Extrahepatic Bile Duct Cancer Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Extrahepatic Bile Duct Cancer, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com